The COVID-19 pandemic has changed much about the way healthcare is delivered. From new CMS codes for Telehealth visits to new advances in Telehealth platforms—and now an At-Home Administration option for capsule endoscopy with the CapsoCam Plus® System for eligible patients.
In the new COVID-19 environment …what matters?
All of the above attributes are part of the unique design you get with the CapsoCam Plus Capsule Endoscopy System.
“The COVID-19 pandemic has challenged all physicians to rethink the way we deliver care now and going forward. We need to do everything possible to continue to deliver healthcare in a timely and safe manner while making an effort to reduce in-person contact and potential Coronavirus exposure. The CapsoCam Plus system will now allow us to offer this procedure to the appropriate patients efficiently and effectively, without the patient needing to visit the clinic. This is an added value to our practice and enables us to reduce exposure risks to our patients and staff while continuing the normal volume of office visits.”
Javier Parra, MD, Gastroenterologist, Gastro Health
Get the latest CapsoVision news, updates on diagnostic imaging of the gastrointestinal system, and tips to improve clinical outcomes and patient quality of life.
Contact & Connect
CapsoVision, Inc.
18805 Cox Avenue #250
Saratoga, CA 95070
Phone: 1-408-624-1488
Fax: 1-408-370-4795
US: The CapsoCam Plus® video capsule system is intended for visualization of the small bowel mucosa in adults. It may be used as a tool in the detection of abnormalities of the small bowel. CapsoCam Plus has been cleared by the U.S. Food and Drug Administration.
International: The CapsoCam Plus® video capsule system is intended for visualization of the small bowel mucosa in patients ages two and above. It may be used as a tool in the detection of abnormalities of the small bowel.
© Copyright 2023 | Privacy Policy | Cookie Policy | All Rights Reserved
ADV-5931 Rev C